Global Med Technologies(R), Inc. Submits ElDorado Donor Doc(TM) To FDA

Main Category: Blood / Hematology
Also Included In: Transplants / Organ Donations;  Medical Devices / Diagnostics;  IT / Internet / E-mail
Article Date: 13 Mar 2007 - 0:00 PDT

email to a friend   printer friendly   opinions  

Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), announced today that it has submitted a 510(k) for its ElDorado Donor Doc(TM) software for clearance by the U.S. Food and Drug Administration (FDA). ElDorado Donor Doc is currently not for sale in the U.S., pending 510(k) clearance by the FDA.

Donor Doc is an electronic health history questionnaire and physical exam tracking system intended to assist blood donor centers with screening donors and capturing relevant medical information. This software has been designed to automate screening processes to provide data quality assurance and supporting regulatory compliance. The software is intended to interface with central blood management systems, to allow easy access to donation information, to identify missing or suspect data, to record physical exam results, as well as to capture digital signatures and donor photographs.

This software is also intended to allow donors to self-administer electronic questionnaires at their own pace, with options such as audio or text in their own language and graphics to help convey the meaning of a question.

Donor Doc was designed with significant input from the blood bank industry and Wyndgate customers. The company organized a technology work group consisting of leading industry representatives from around the world during development and beta testing of the software.

Michael I. Ruxin, M.D., Chairman and CEO of Global Med Technologies, commented, "Global Med Technologies and Wyndgate Technologies are pleased to have submitted Donor Doc for FDA 510(k) clearance. We continue to strive to deliver products that our customers request and need. We appreciate the contributions of our customers to all of our products, and we are confident in the quality and functionality of Donor Doc. Our technology work group has been invaluable throughout this process, and we thank them. We look forward to the response from the FDA regarding clearance for Donor Doc."

About Global Med Technologies, Inc.

Global Med Technologies, Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the SafeTrace Tx(R) advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.

Global Med Technologies, Inc.
http://www.globalmedtech.com

• Additional
• References
• Citations